The antifolate compounds IOdeazaaminopterin (lOdAM) and IO-ethyl-IOdeazaaminopterin ( IO-EdAM) are therapeutically superior to methotrexate in transplanted murine tumor systems and in human tumor xenografts growing in immunodeficient "nude" mice. The increased therapeutic index of these analogs corr
Folate analogues: 27. syntheses of 14carbon-labeled 10-deazaaminopterin and 10-ethyl-10-deazaaminopterin
โ Scribed by M. M. Nair; Nitin T. Nanavati
- Book ID
- 102375674
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 286 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
โฆ Synopsis
vevsi ty o f South A1 abama Mobile, AL 36688 SUMARY 10-Deazaaminopterin (1) and 10-Ethyl-10-deazaaminopterin ( 2 )
labeled uniformly w i t h 14C a t the glutamate moiety were prepared by the following procedure. Uniformly labeled L-glutamic acid was converted t o i t s dimethyl ester (3). -4-Amino-4-deoxy-10-deazapteroic a c i d ( 4)
and 4-amino-4-deoxy-10ethyl-10-deazapteroic acid (5) were converted t o t h e i r respective mixed anhydrides 6 and 7 w i t h isobutylchloroformate.
labeled dimethyl-L-gl utamate gave dimethyl-10-deazaaminopterin (
and dimethyl 10-ethyl-10-deazaaminopterin (9)respectively, which on m i l d a l k a l i n e hydrolysis gave the t a r g e t compounds -1 and -2 i n .~22-25% y i e l d , based on the amount of radiolabeled glutamic acid used.
๐ SIMILAR VOLUMES
lo-ethyl-1 0-deazaaminopterin (1 0-EDAM) is a rationally designed derivative of the antifolate. methotrexate (MTX). In a number of tumor models these design features have resulted in an improved spectrum of antiproliferative activity as compared with the parent compound. Using an MTT growth assay, w